Report cover image

Mitsubishi Tanabe Pharma Corp - Strategic SWOT Analysis Review

Publisher GlobalData
Published Feb 28, 2025
Length 41 Pages
SKU # GBDT19677369

Description

Mitsubishi Tanabe Pharma Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights

Mitsubishi Tanabe Pharma Corp (Mitsubishi Tanabe), a subsidiary of Mitsubishi Chemical Holdings Corp, identifies, develops, manufactures, procures, and commercializes ethical drugs and over-the-counter (OTC) pharmaceutical products. The company develops ethical drugs for autoimmune diseases, diabetes, kidney diseases, central nervous system (CNS) disorders, and others. It also develops vaccines for preventing various infectious diseases. Mitsubishi Tanabe also offers major products for skin conditions and digestive medicines. The company markets its products to wholesalers, hospitals, clinics, and drugstores. It has subsidiaries in Asia, Europe, and North America. Mitsubishi Tanabe is headquartered in Osaka, Japan.

Mitsubishi Tanabe Pharma Corp Key Recent Developments

Jan 10,2025: Synaffix secures ADC deals with Boehringer and Mitsubishi Tanabe
Dec 12,2024: Announcement of Organizational Changes and Personnel Changes of the Mitsubishi Group
May 09,2024: Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions
May 09,2024: The Global Health Innovative Technology Fund Provides Grant to Mitsubishi Tanabe Pharma and DNDi for Chagas Disease Drug Discover

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.

Table of Contents

41 Pages
Section 1 - About the Company
Mitsubishi Tanabe Pharma Corp - Key Facts
Mitsubishi Tanabe Pharma Corp - Key Employees
Mitsubishi Tanabe Pharma Corp - Major Products and Services
Mitsubishi Tanabe Pharma Corp - History
Mitsubishi Tanabe Pharma Corp - Company Statement
Mitsubishi Tanabe Pharma Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Mitsubishi Tanabe Pharma Corp - Business Description
R&D Overview
Mitsubishi Tanabe Pharma Corp - SWOT Analysis
SWOT Analysis - Overview
Mitsubishi Tanabe Pharma Corp - Strengths
Mitsubishi Tanabe Pharma Corp - Weaknesses
Mitsubishi Tanabe Pharma Corp - Opportunities
Mitsubishi Tanabe Pharma Corp - Threats
Mitsubishi Tanabe Pharma Corp - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
Mitsubishi Tanabe Pharma Corp, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jan 10, 2025: Synaffix secures ADC deals with Boehringer and Mitsubishi Tanabe
Dec 12, 2024: Announcement of Organizational Changes and Personnel Changes of the Mitsubishi Group
May 09, 2024: Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based Institutions
May 09, 2024: The Global Health Innovative Technology Fund Provides Grant to Mitsubishi Tanabe Pharma and DNDi for Chagas Disease Drug Discover
Mar 04, 2024: Expiration of Marketing Alliance Agreement for TENELIA Tablets, TENELIA OD Tablets and CANAGLU Tablets
Feb 27, 2024: Announcement of Organizational Changes and Personnel Changes of the Mitsubishi Chemical Group
Jan 26, 2024: Mitsubishi Tanabe Pharma Contribute Funding To Global Health Innovative Technology Fund’s Third Phase ―Targeting Treatments for Infectious Diseases That Burden the Developing World
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Mitsubishi Tanabe Pharma Corp, Key Facts
Mitsubishi Tanabe Pharma Corp, Key Employees
Mitsubishi Tanabe Pharma Corp, Major Products and Services
Mitsubishi Tanabe Pharma Corp, History
Mitsubishi Tanabe Pharma Corp, Other Locations
Mitsubishi Tanabe Pharma Corp, Subsidiaries
Mitsubishi Tanabe Pharma Corp, Joint Venture
Mitsubishi Tanabe Pharma Corp, Key Competitors
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
Mitsubishi Tanabe Pharma Corp, Recent Deals Summary
List of Figures
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us